Drug Type Small molecule drug |
Synonyms Talaglumetad, Talaglumetad hydrochloride (USAN) + [1] |
Target |
Mechanism mGluR2 agonists(Metabotropic glutamate receptor 2 agonists), mGluR3 agonists(Metabotropic glutamate receptor 3 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC11H17ClN2O5 |
InChIKeyTWZDLCLCMKMJPE-OAOSNHGPSA-N |
CAS Registry441765-97-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09008 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Phase 3 | US | 01 Jul 2007 |